What is the Projected CAGR value of the Cancer Stem Cells Market?
Cancer Stem Cells Market is expected to grow at a CAGR of 6.7% during the forecast period 2024-2031.
Who are the key players in Cancer Stem Cells Market?
key players are Merck KGaA, Thermo Fisher Scientific, Inc., Bionomics, AbbVie, Inc., Stemline Therapeutics, Inc, LONZA, PromoCell GmbH, Miltenyi Biotec, STEMCELL Technologies Inc and BIOTIME, Inc.